Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis

ClinicalTrials.gov ID: NCT00091975

Public ClinicalTrials.gov record NCT00091975. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Evaluate the Safety and Efficacy of Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to determine the safety and efficacy of Zemplar® Capsule versus placebo, in decreasing elevated intact parathyroid hormone levels in chronic kidney disease stage 5 subjects with secondary hyperparathyroidism on hemodialysis or peritoneal dialysis, while using the revised dose titration scheme.

Study identification

NCT ID
NCT00091975
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
78 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2004 (Type not available)
Primary completion
Not listed
Completion
Not listed
Last update posted
Jan 19, 2011

Started 2004

United States locations

U.S. sites
16
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
California Institute of Renal Research San Diego California 92120 —
Georgetown University Medical Center Washington D.C. District of Columbia 60057 —
Associates in Nephrology Fort Meyers Florida 33908 —
University of Florida Gainesville Florida 32610 —
Outcomes Research International, Inc. Hudson Florida 34667 —
Evanston Northwestern Healthcare Evanston Illinois 60201 —
Indiana University School of Medicine Indianapolis Indiana 46202 —
Tulane University School of Medicine New Orleans Louisiana 70112-2699 —
Washington University Medical Center St Louis Missouri 63108 —
St. Louis University St Louis Missouri 63110 —
Nea Research Las Vegas Nevada 89102 —
University of Cincinnati College of Medicine Cincinnati Ohio 45267-0585 —
Northwestern Renal Clinic, INC. Portland Oregon 97210 —
Nephrology Associates, P.C. Nashville Tennessee 37205 —
Kidney Associates, PLLC Houston Texas 77030 —
University of Texas Health Center at San Antonio San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00091975, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 19, 2011 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00091975 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →